Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to see what effects, good and/or bad, proton based radiation combined with low dose chemotherapy and hormonal therapy, has on patients and their cancer.

Key facts

Study ID

NCT01040624

Run by

University of Florida

People needed

77

Starts

2009-12-01

Expected to finish

2022-04-11

Last updated by the study team

2023-10-03

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Adenocarcinoma of the prostate.

You may not qualify if…

• Previous prostate cancer treatment such as chemotherapy and/or pelvic radiation.
• Active inflammatory bowel disease (diverticulitis, Crohn's disease or ulcerative colitis) affecting the rectum. (Non-active diverticulitis and Crohn's disease not affecting the rectum are allowed.)
• History of hip replacement.
• Prior intrapelvic surgery. This includes the following:
• Transrectal or rectal surgery other than polypectomy or hemorrhoid removal or banding
• Transabdominal pelvic surgery
• Bladder surgery
• Prior myocardial infarction (MI) or congestive heart failure (CHF).
• Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.

Where it is running

• University of Florida Proton Therapy Institute — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.